Trial Profile
A Study to Evaluate the Evolution of Genotypic Mutations Within the Reverse Transcriptase Region in Partial Virological Responders Who Received Long-Term Entecavir Therapy for Hepatitis B
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jun 2016
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics; Pharmacogenomic
- 28 Jun 2016 New trial record